Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet

Por um escritor misterioso

Descrição

Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Management of Hypertension in Pregnancy
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
The Pathogenesis and Treatment of Cardiovascular Autonomic Dysfunction in Parkinson's Disease: What We Know and Where to Go
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
PDF) Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open- label, randomised controlled trial
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
PDF) Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open- label, randomised controlled trial
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Præeklampsi - patologi, risikofaktorer, behandling og efterforløb - Jordemoderforeningen
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Prevention Starts in the Womb: Opportunities for Addressing Cardiovascular Risk Factors During Pregnancy and Beyond - Methodist DeBakey Cardiovascular J
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
IJERPH, Free Full-Text
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
ABC Cardiol
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Clinical Evaluation of Pinggan Yiqi Yangshen Recipe Combined with Labetalol Hydrochloride and Magnesium Sulfate in the Treatment of PIH
de por adulto (o preço varia de acordo com o tamanho do grupo)